Lília Nigro Maia
Universidade Federal do Rio de Janeiro(BR)Hospital de Base(BR)D’Or Institute for Research and Education(BR)Hospital de Base(BR)
Publications by Year
Research Areas
Cardiac, Anesthesia and Surgical Outcomes, Diabetes Treatment and Management, Acute Myocardial Infarction Research, Atrial Fibrillation Management and Outcomes, Hemodynamic Monitoring and Therapy
Most-Cited Works
- → Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial(2017)864 cited
- → Rivaroxaban with or without aspirin in patients with stable coronary artery disease: an international, randomised, double-blind, placebo-controlled trial(2017)750 cited
- → Therapeutic versus prophylactic anticoagulation for patients admitted to hospital with COVID-19 and elevated D-dimer concentration (ACTION): an open-label, multicentre, randomised, controlled trial(2021)490 cited
- → Tofacitinib in Patients Hospitalized with Covid-19 Pneumonia(2021)440 cited
- → Dapagliflozin in patients with cardiometabolic risk factors hospitalised with COVID-19 (DARE-19): a randomised, double-blind, placebo-controlled, phase 3 trial(2021)237 cited
- →